Saxagliptin

In the US, Saxagliptin (saxagliptin systemic) is a member of the drug class dipeptidyl peptidase 4 inhibitors and is used to treat Diabetes, Type 2.

US matches:

• Saxagliptin


• Saxagliptin/Metformin Extended-Release Tablets


• Saxagliptin and metformin


• Saxagliptin/Metformin Hydrochloride

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A10BH03

CAS registry number (Chemical Abstracts Service)

0361442-04-8

Chemical Formula

C18-H25-N3-O2

Molecular Weight

315

Therapeutic Category

Oral antidiabetic agent, dipeptidyl peptidase-4 (DPP-4) inhibitor, gliptin

Chemical Names

(1S,3S,5S)-2-[(2S)-Amino(3-hydroxytricyclo[3.3.1.1³,⁷]dec-1-yl)acetyl]-2-azabicyclo[3.1.0]-hexane-3-carbonitrile (USAN)

(1S,3S,5S)-2-{(2S)-2-amino-2-(3-hydroxyadamantan-1-yl)acetyl}-2-azabicyclo[3.1.0]hexane-3-carbonitrile (WHO)

2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-amino(3-hydroxytricyclo[3.3.1.1³,⁷]dec-1-yl)acetyl]-, (1S,3S,5S)- (USAN)

Foreign Names

• Saxagliptinum (Latin)
• Saxagliptin (German)
• Saxagliptine (French)
• Saxagliptina (Spanish)

Generic Names

• Saxagliptin (OS: USAN)
• BMS 477118 (IS)
• OPC-262 (IS)
• UNII-8I7IO46IVQ (IS)
• UNII-Z8J84YIX6L (IS)

Brand Names

• Onglyza
  AstraZeneca, Belgium; AstraZeneca, Switzerland; AstraZeneca, United Kingdom; Bristol-Myers Squibb, United Kingdom; Bristol-Myers Squibb, Greece; Bristol-Myers Squibb, Sweden; Bristol-Myers Squibb, United States; Bristol-Myers Squibb/AstraZeneca, Germany

International Drug Name Search

Glossary

IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.